Liver dialysis breakthrough? new device could save lives in severe liver failure

NCT ID NCT07347275

First seen Jan 18, 2026 · Last updated May 16, 2026 · Updated 18 times

Summary

This study tests a device called DIALIVE 2.0, which acts like a dialysis machine for the liver, in people with acute-on-chronic liver failure (ACLF) grades 2-4. About 72 adults aged 18-70 with liver cirrhosis and recent worsening will either receive standard care or standard care plus up to 7 daily sessions with the device. The goal is to see if the device helps resolve liver failure and improves survival without needing a liver transplant.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LIVER CIRRHOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.